Iain Stuart - Net Worth and Insider Trading

Iain Stuart Net Worth

The estimated net worth of Iain Stuart is at least $189,937 dollars as of 2024-06-15. Iain Stuart is the Chief Scientific Officer of Foamix Pharmaceuticals Ltd and owns about 63,524 shares of Foamix Pharmaceuticals Ltd (FOMX) stock worth over $189,937. Details can be seen in Iain Stuart's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Iain Stuart has not made any transactions after 2019-07-01 and currently still holds the listed stock(s).

Transaction Summary of Iain Stuart

To

Iain Stuart Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Iain Stuart owns 2 companies in total, including VYNE Therapeutics Inc (VYNE) , and Foamix Pharmaceuticals Ltd (FOMX) .

Click here to see the complete history of Iain Stuart’s form 4 insider trades.

Insider Ownership Summary of Iain Stuart

Ticker Comapny Transaction Date Type of Owner
VYNE VYNE Therapeutics Inc 2020-03-09 Chief Scientific Officer
FOMX Foamix Pharmaceuticals Ltd 2020-03-09 Chief Scientific Officer

Iain Stuart Latest Holdings Summary

Iain Stuart currently owns a total of 1 stock. Iain Stuart owns 63,524 shares of Foamix Pharmaceuticals Ltd (FOMX) as of July 1, 2019, with a value of $189,937.

Latest Holdings of Iain Stuart

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FOMX Foamix Pharmaceuticals Ltd 2019-07-01 63,524 2.99 189,937

Holding Weightings of Iain Stuart


Iain Stuart Form 4 Trading Tracker

According to the SEC Form 4 filings, Iain Stuart has made a total of 1 transactions in Foamix Pharmaceuticals Ltd (FOMX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Foamix Pharmaceuticals Ltd is the sale of 951 shares on July 1, 2019, which brought Iain Stuart around $2,235.

Insider Trading History of Iain Stuart

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Iain Stuart Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Iain Stuart Ownership Network

Ownership Network List of Iain Stuart

No Data

Ownership Network Relation of Iain Stuart

Insider Network Chart

Iain Stuart Owned Company Details

What does VYNE Therapeutics Inc do?

Who are the key executives at VYNE Therapeutics Inc?

Iain Stuart is the Chief Scientific Officer of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include Chief Legal Officer and GC Mutya Harsch , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Interim CFO Tyler Zeronda .

VYNE Therapeutics Inc (VYNE) Insider Trades Summary

Over the past 18 months, Iain Stuart made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 33,000 shares made by Patrick G Lepore , and a net purchase of 10,000 shares made by Mutya Harsch .

In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 43,000 shares were bought by its insiders, resulting in a net purchase of 43,000 shares.

VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

VYNE Therapeutics Inc Insider Transactions

No Available Data

Iain Stuart Mailing Address

Above is the net worth, insider trading, and ownership report for Iain Stuart. You might contact Iain Stuart via mailing address: C/o Foamix Pharmaceuticals Ltd., 2 Holzman Street, Weizmann Science Park, Rehovot L3 76704.

Discussions on Iain Stuart

No discussions yet.